In recent years, US Food and Drug Administration rulemaking marked OTC antibacterial soaps and hand sanitizers as categories in danger, citing insufficient safety and efficacy data and concerns about the products’ possible contribution to bacterial resistance.
Then came COVID-19 and a global explosion in demand for hand sanitizers, wipes and other OTC germ-killing products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?